$0.5B license deal 2014 on cards $AMBS a $500-M
Post# of 30027
Posted On: 07/13/2014 4:14:24 PM
Quote:
$0.5B license deal 2014 on cards $AMBS
a $500-Mil. LymPro licensing deal with 10% upfront ($50-Mil.) would not surprise me at all
but it will most assuredly surprise the market and the Street
according to GC:
Quote:
"we may not need to do a RS"
does anyone truly understand the ramifications of that statement?
Risk and I were discussing this exact topic (+ a few others) for an hour yesterday
the minimum share price for a NASDAQ uplisting is $2.00
curious for feedback......
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼